AGC Biologics honored at the 2025 CDMO Leadership Awards
AGC Biologics has been recognized for excellence in three different categories at this year's CDMO Leadership awards event, including being named a top CDMO for both Global Biologics and Global Cell & Gene Therapies. Additionally, we were named Best in Quality Management Systems, highlighting the expertise of our quality teams working together across our global network. We are honored to receive these recognitions and aim to continue to push ourselves farther as we work toward bringing hope to life.
Watch the video below to hear Alberto Santagostino, CEO of AGC Biologics, accept these honors at the awards ceremony.
From Strain to Scale: A Modern Roadmap for Reliable E. Coli-based Microbial Biomanufacturing
November 21, 2025 at 11:01 AM
Trends Shaping the Future of Cell and Gene Therapy Manufacturing
October 29, 2025 at 3:59 PM
